Streetbeat News

Products Services

JOBY

Joby Aviation, Inc. (NYSE:JOBY) has received FAA approval for its propulsion certification plan, a crucial step towards obtaining type certification for its electric air taxi. This approval encompasses all structural, mechanical, and electrical systems, positioning Joby as a leader in the electric air taxi certification process. The company has completed 30 for-credit tests with the FAA in 2023 and recently received its Part 145 Maintenance Certificate, further advancing its path to commercialization. Joby's air taxi aims to offer high-speed, low-noise, and zero-emission passenger service.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 2:01 pm

IRON

Disc Medicine has been granted FDA Orphan Drug Designation for DISC-3405, a treatment for Polycythemia Vera, a type of blood cancer. This designation is significant as it provides benefits such as tax credits, eligibility for market exclusivity, and assistance in the drug development process.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 2:01 pm

COO

FLGT

CooperSurgical has announced a partnership with Fulgent Genetics to launch genetic screening panels, aimed at providing CBR families with proactive health information for their children. This collaboration combines CooperSurgical's expertise in women's health with Fulgent Genetics' advanced genetic testing capabilities.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 1:39 pm

COLB

NOBL

TSLA

UBER

On CNBC's 'Halftime Report Final Trades,' analysts highlighted ProShares S&P 500 Dividend Aristocrats ETF (NOBL), Columbia Banking System, Inc. (COLB), Tesla, Inc. (TSLA), and Uber Technologies, Inc. (UBER). Columbia Banking reported weaker-than-expected Q4 results, while Tesla cut prices on its Model Y in Canada. Uber reported better-than-expected Q4 sales. Shares of COLB, NOBL, TSLA, and UBER all saw movements in their stock prices following these updates.

Portfolio Pulse from Avi Kapoor

February 09, 2024 | 1:38 pm

BLIN

Bridgeline Digital, Inc. (NASDAQ:BLIN) announced that Schaedler Yesco, an Electrical Distribution Company, has chosen Bridgeline's HawkSearch to enhance its website's search capabilities. HawkSearch will improve Schaedler Yesco's eCommerce strategy with advanced search functionalities tailored to the electrical industry, including part number search and unit of measurement conversion. This partnership highlights Bridgeline's growing influence in the electrical distribution market.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 1:37 pm

DLTR

Dollar Tree, Inc. (NASDAQ:DLTR) announced the expansion of COO Mike Creedon's role to include leadership of Dollar Tree & Family Dollar Merchandising and Supply Chain. This move is part of the company's transformation strategy, aiming to enhance store experience for customers. Creedon, who joined Dollar Tree in 2022, previously held leadership roles at Advance Auto Parts, Tyco International, and ADT Security. The company's leadership believes this change will positively impact the execution of its transformation plan.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 1:37 pm

GURE

Gulf Resources, Inc. (GURE) provided an update on the Yuxin Chemical factory, indicating a delay in ordering remaining equipment due to the weak Chinese economy, particularly in the housing market which significantly consumes bromine. The company is exploring other market segments, including pharmaceuticals and sodium-ion batteries, as potential areas for growth. GURE is also monitoring geopolitical tensions in the Middle East, which could impact global bromine markets. The company is considering the production of sodium-ion batteries as a future direction, depending on the economic situation.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 1:36 pm

BIOL

CNSP

GILD

REVB

ZLAB

The article highlights the top 5 oversold health care stocks preparing for potential growth in February, based on their Relative Strength Index (RSI) values. BIOLASE, CNS Pharmaceuticals, Revelation Biosciences, Gilead Sciences, and Zai Lab Limited are identified as major players with RSI near or below 30, indicating they may be undervalued. Recent company updates and stock performance are also provided.

Portfolio Pulse from Avi Kapoor

February 09, 2024 | 1:35 pm

ABBV

FCX

MELI

OXLC

Jim Cramer discussed several companies on CNBC's 'Mad Money Lightning Round,' highlighting potential in Freeport-McMoRan with a new CEO, praising AbbVie's Parkinson's treatment in Canada, commending MercadoLibre's intelligence and financial results, and suggesting Blackstone over Oxford Lane Capital for credit expertise. He noted Freeport-McMoRan's limited upside, AbbVie's strength, MercadoLibre's smart management, and uncertainties around Oxford Lane Capital.

Portfolio Pulse from Avi Kapoor

February 09, 2024 | 1:33 pm

NVDA

TSM

Taiwan Semiconductor Manufacturing Co (TSMC) is expanding its global footprint by constructing a second factory in Japan, aiming to diversify chip production and reduce reliance on its Taiwan facilities. The new plant in Kumamoto will produce advanced 6-nanometer chips and is expected to be operational by 2027. This expansion is part of TSMC's strategy to increase its production capacity outside Taiwan to over 20% by 2028. The company's stock (TSM) saw a premarket increase of 0.76% to $134.74, following a 38% gain last year driven by the AI technology demand surge.

Portfolio Pulse from Anusuya Lahiri

February 09, 2024 | 1:23 pm